Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy

In conclusion, IL-6 levels were found to be predictive of the likelihood of remission.
Source: Clinical and Experimental Medicine - Category: Research Source Type: research